23andMe Holding Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for 23andMe Holding.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Healthcare earnings growth | 19.8% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
Recent updates
Here's Why We're A Bit Worried About 23andMe Holding's (NASDAQ:ME) Cash Burn Situation
Apr 16Risks Still Elevated At These Prices As 23andMe Holding Co. (NASDAQ:ME) Shares Dive 26%
Mar 02We're Keeping An Eye On 23andMe Holding's (NASDAQ:ME) Cash Burn Rate
Jul 1323andMe Holding Co. (NASDAQ:ME) Investors Are Less Pessimistic Than Expected
Jun 1523andMe: Disappointing Results Could Mean Potential Acquisition Target
Sep 2723andMe: Treacherous Path To Profitability
Aug 2623andMe drops 8% as CFO resigns
Aug 1923andMe Holding Co. (NASDAQ:ME) Just Reported, And Analysts Assigned A US$5.00 Price Target
Aug 1123andMe Q1 2023 Earnings Preview
Aug 0723andMe: Holiday Miracles Not Enough, Growth Path Too Expensive
Jun 1523andMe: A Genetics Innovator Positioned For Growth
Feb 19Need To Know: Analysts Are Much More Bullish On 23andMe Holding Co. (NASDAQ:ME) Revenues
Feb 1823andMe: No Surprises With Recent Earnings, But Long-Term Story Remains Positive
Nov 2123andMe Stock: Continued Drug-Development Progress Can Deliver Long-Term Gains
Oct 03Companies Like 23andMe Holding (NASDAQ:ME) Are In A Position To Invest In Growth
Sep 1723andMe: New Therapeutic Pipeline And PGS Product Growth Catalyzed By +$696M In SPAC Funding
Jul 19In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as 23andMe Holding has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2024 | 199 | -631 | -146 | -138 | N/A |
3/31/2024 | 220 | -667 | -174 | -164 | N/A |
12/31/2023 | 248 | -522 | -194 | -183 | N/A |
9/30/2023 | 270 | -336 | -158 | -146 | N/A |
6/30/2023 | 296 | -327 | -173 | -162 | N/A |
3/31/2023 | 299 | -312 | -177 | -165 | N/A |
12/31/2022 | 308 | -317 | -167 | -156 | N/A |
9/30/2022 | 298 | -315 | -216 | -206 | N/A |
6/30/2022 | 277 | -265 | -211 | -195 | N/A |
3/31/2022 | 272 | -217 | -181 | -167 | N/A |
12/31/2021 | 260 | -215 | -183 | -172 | N/A |
9/30/2021 | 259 | -170 | -130 | -119 | N/A |
6/30/2021 | 255 | -190 | -90 | -86 | N/A |
3/31/2021 | 244 | -184 | -82 | -74 | N/A |
3/31/2020 | 305 | -251 | -259 | -186 | N/A |
3/31/2019 | 441 | -184 | -126 | -98 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if ME's forecast earnings growth is above the savings rate (2.5%).
Earnings vs Market: Insufficient data to determine if ME's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if ME's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if ME's revenue is forecast to grow faster than the US market.
High Growth Revenue: Insufficient data to determine if ME's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ME's Return on Equity is forecast to be high in 3 years time